Point72 Hong Kong LTD Vertex Pharmaceuticals Inc Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $4.57 Million - $5.1 Million
16,683 New
16,683 $4.83 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $2.08 Million - $2.45 Million
-9,403 Reduced 98.09%
183 $48,000
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $2.77 Million - $3.5 Million
-15,655 Reduced 62.02%
9,586 $2.11 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $4.44 Million - $4.96 Million
24,457 Added 3119.52%
25,241 $4.58 Million
Q1 2021

May 17, 2021
BUY
$207.02 - $241.31 $162,303 - $189,187
784 New
784 $168,000
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $104,479 - $129,604
-523 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$166.71 - $223.91 $578,983 - $777,639
-3,473 Reduced 86.91%
523 $115,000
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $257,988 - $290,363
1,552 Added 63.5%
3,996 $677,000
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $402,306 - $465,264
2,444 New
2,444 $448,000
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $818 - $973
-5 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$151.91 - $192.21 $759 - $961
5 New
5 $1,000
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $143,534 - $167,410
-985 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$151.6 - $177.13 $149,326 - $174,473
985 New
985 $161,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email